48
Views
144
CrossRef citations to date
0
Altmetric
Transcriptional Regulation

Differential Transactivation by the p53 Transcription Factor Is Highly Dependent on p53 Level and Promoter Target Sequence

, , &
Pages 8612-8625 | Received 24 May 2002, Accepted 10 Sep 2002, Published online: 28 Mar 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Daniel Menendez, Alberto Inga, Joyce Snipe, Oliver Krysiak, Gilbert Schönfelder & Michael A. Resnick. (2007) A Single-Nucleotide Polymorphism in a Half-Binding Site Creates p53 and Estrogen Receptor Control of Vascular Endothelial Growth Factor Receptor 1. Molecular and Cellular Biology 27:7, pages 2590-2600.
Read now
Motonobu Osada, Hannah Lui Park, Yuichi Nagakawa, Keishi Yamashita, Alexey Fomenkov, Myoung Sook Kim, Guojun Wu, Shuji Nomoto, Barry Trink & David Sidransky. (2005) Differential Recognition of Response Elements Determines Target Gene Specificity forp53 and p63. Molecular and Cellular Biology 25:14, pages 6077-6089.
Read now
Séverine Seemann, Daniela Maurici, Magali Olivier, Claude Caron Fromentel & Pierre Hainaut. (2004) The Tumor Suppressor Gene TP53: Implications for Cancer Management and Therapy. Critical Reviews in Clinical Laboratory Sciences 41:5-6, pages 551-583.
Read now

Articles from other publishers (141)

Ambritha Balasundaram & C. George Priya Doss. (2022) Unraveling the Structural Changes in the DNA-Binding Region of Tumor Protein p53 (TP53) upon Hotspot Mutation p53 Arg248 by Comparative Computational Approach. International Journal of Molecular Sciences 23:24, pages 15499.
Crossref
Lei Wang, Xiaojun Tan, Lu Chen, Sisi Xu, Weiping Huang, Nan Chen, Yizhou Wu, Chunyan Wang, Daqiang Zhou & Mangmang Li. (2022) Sall4 Guides p53-Mediated Enhancer Interference upon DNA Damage in Mouse Embryonic Stem Cells. Stem Cells 40:11, pages 1008-1019.
Crossref
Paola Monti, Silvia Ravera, Andrea Speciale, Irena Velkova, Giorgia Foggetti, Paolo Degan, Gilberto Fronza & Paola Menichini. (2022) Mutant p53K120R expression enables a partial capacity to modulate metabolism. Frontiers in Genetics 13.
Crossref
Marta Rigoli, Giovanni Spagnolli, Giulia Lorengo, Paola Monti, Raffaello Potestio, Emiliano Biasini & Alberto Inga. (2022) Structural Basis of Mutation-Dependent p53 Tetramerization Deficiency. International Journal of Molecular Sciences 23:14, pages 7960.
Crossref
Vera V. Grinkevich, Aparna Vema, Karin Fawkner, Natalia Issaeva, Virginia Andreotti, Eleanor R. Dickinson, Elisabeth Hedström, Clemens Spinnler, Alberto Inga, Lars-Gunnar Larsson, Anders Karlén, Margareta Wilhelm, Perdita E. Barran, Andrei L. Okorokov, Galina Selivanova & Joanna E. Zawacka-Pankau. (2022) Novel Allosteric Mechanism of Dual p53/MDM2 and p53/MDM4 Inhibition by a Small Molecule. Frontiers in Molecular Biosciences 9.
Crossref
Akkinepally Vanaja & Venkata Rajesh Yella. (2022) Delineation of the DNA Structural Features of Eukaryotic Core Promoter Classes. ACS Omega 7:7, pages 5657-5669.
Crossref
Huan-Chieh Cho, Yenlin Huang, Jung-Tung Hung, Tsai-Hsien Hung, Kai-Chun Cheng, Yun-Hen Liu, Ming-Wei Kuo, Sheng-Hung Wang, Alice L. Yu & John Yu. (2022) Puf-A promotes cancer progression by interacting with nucleophosmin in nucleolus. Oncogene 41:8, pages 1155-1165.
Crossref
Akkinepally Vanaja, Sarada Prasanna Mallick, Umasankar Kulandaivelu, Aditya Kumar & Venkata Rajesh Yella. (2021) Symphony of the DNA flexibility and sequence environment orchestrates p53 binding to its responsive elements. Gene 803, pages 145892.
Crossref
Zahra Hasanpour Segherlou, Masoud Nouri‐Vaskeh, Sama Noroozi Guilandehi, Amir Baghbanzadeh, Ramin Zand, Behzad Baradaran & Mohammad Zarei. (2021) GDF‐15: Diagnostic, prognostic, and therapeutic significance in glioblastoma multiforme. Journal of Cellular Physiology 236:8, pages 5564-5581.
Crossref
Xiaomin Shi. (2021) A Hill type equation can predict target gene expression driven by p53 pulsing. FEBS Open Bio 11:6, pages 1799-1808.
Crossref
Flora Doffe, Vincent Carbonnier, Manon Tissier, Bernard Leroy, Isabelle Martins, Johanna S. M. Mattsson, Patrick Micke, Sarka Pavlova, Sarka Pospisilova, Jana Smardova, Andreas C. Joerger, Klas G. Wiman, Guido Kroemer & Thierry Soussi. (2020) Identification and functional characterization of new missense SNPs in the coding region of the TP53 gene. Cell Death & Differentiation 28:5, pages 1477-1492.
Crossref
Alon Senitzki, Jessy Safieh, Vasundhara Sharma, Dmitrij Golovenko, Yael Danin-Poleg, Alberto Inga & Tali E Haran. (2021) The complex architecture of p53 binding sites. Nucleic Acids Research 49:3, pages 1364-1382.
Crossref
Paola Monti, Vaclav Brazda, Natália Bohálová, Otília Porubiaková, Paola Menichini, Andrea Speciale, Renata Bocciardi, Alberto Inga & Gilberto Fronza. (2021) Evaluating the Influence of a G-Quadruplex Prone Sequence on the Transactivation Potential by Wild-Type and/or Mutant P53 Family Proteins through a Yeast-Based Functional Assay. Genes 12:2, pages 277.
Crossref
Jan K. Hennigs, Aiqin CaoCaiyun G. LiMinyi ShiJulia MienertKazuya MiyagawaJakob Körbelin, David P. MarcianoPin-I ChenMatthew RoughleyMatthew V. Elliott, Rebecca L. HarperMatthew A. BillJames Chappell, Jan-Renier MoonenIsabel DieboldLingli WangMichael P. SnyderMarlene Rabinovitch. (2021) PPARγ-p53-Mediated Vasculoregenerative Program to Reverse Pulmonary Hypertension. Circulation Research 128:3, pages 401-418.
Crossref
Marina Farkas, Hideharu Hashimoto, Yingtao Bi, Ramana V. Davuluri, Lois Resnick-Silverman, James J. Manfredi, Erik W. Debler & Steven B. McMahon. (2021) Distinct mechanisms control genome recognition by p53 at its target genes linked to different cell fates. Nature Communications 12:1.
Crossref
Morgan A Sammons, Thuy-Ai T Nguyen, Simon S McDade & Martin Fischer. (2020) Tumor suppressor p53: from engaging DNA to target gene regulation. Nucleic Acids Research 48:16, pages 8848-8869.
Crossref
Domenica Ronchetti, Vanessa Favasuli, Paola Monti, Giovanna Cutrona, Sonia Fabris, Ilaria Silvestris, Luca Agnelli, Monica Colombo, Paola Menichini, Serena Matis, Massimo Gentile, Ramil Nurtdinov, Roderic Guigó, Luca Baldini, Gilberto Fronza, Manlio Ferrarini, Fortunato Morabito, Antonino Neri & Elisa Taiana. (2020) NEAT1 Long Isoform Is Highly Expressed in Chronic Lymphocytic Leukemia Irrespectively of Cytogenetic Groups or Clinical Outcome. Non-Coding RNA 6:1, pages 11.
Crossref
Kanwal Farooqi, Marjan Ghazvini, Leah D. Pride, Louis Mazzella, David White, Ajay Pramanik, Jill Bargonetti & Carol Wood Moore. (2020) A Protein in the Yeast Saccharomyces cerevisiae Presents DNA Binding Homology to the p53 Checkpoint Protein and Tumor Suppressor. Biomolecules 10:3, pages 417.
Crossref
Marco Cordani, Giovanna Butera, Raffaella Pacchiana, Francesca Masetto, Nidula Mullappilly, Chiara Riganti & Massimo Donadelli. (2020) Mutant p53-Associated Molecular Mechanisms of ROS Regulation in Cancer Cells. Biomolecules 10:3, pages 361.
Crossref
Koray Kırımtay, Ece Selçuk, Dolunay Kelle, Batu Erman & Arzu Karabay. (2020) p53 regulates katanin-p60 promoter in HCT 116 cells. Gene 727, pages 144241.
Crossref
Yongchao Dou, Emily A. Kawaler, Daniel Cui Zhou, Marina A. Gritsenko, Chen Huang, Lili Blumenberg, Alla Karpova, Vladislav A. Petyuk, Sara R. Savage, Shankha Satpathy, Wenke Liu, Yige Wu, Chia-Feng Tsai, Bo Wen, Zhi Li, Song Cao, Jamie Moon, Zhiao Shi, MacIntosh Cornwell, Matthew A. Wyczalkowski, Rosalie K. Chu, Suhas Vasaikar, Hua Zhou, Qingsong Gao, Ronald J. Moore, Kai Li, Sunantha Sethuraman, Matthew E. Monroe, Rui Zhao, David Heiman, Karsten Krug, Karl Clauser, Ramani Kothadia, Yosef Maruvka, Alexander R. Pico, Amanda E. Oliphant, Emily L. Hoskins, Samuel L. Pugh, Sean J.I. Beecroft, David W. Adams, Jonathan C. Jarman, Andy Kong, Hui-Yin Chang, Boris Reva, Yuxing Liao, Dmitry Rykunov, Antonio Colaprico, Xi Steven Chen, Andrzej Czekański, Marcin Jędryka, Rafał Matkowski, Maciej Wiznerowicz, Tara Hiltke, Emily Boja, Christopher R. Kinsinger, Mehdi Mesri, Ana I. Robles, Henry Rodriguez, David Mutch, Katherine Fuh, Matthew J. Ellis, Deborah DeLair, Mathangi Thiagarajan, D.R. Mani, Gad Getz, Michael Noble, Alexey I. Nesvizhskii, Pei Wang, Matthew L. Anderson, Douglas A. Levine, Richard D. Smith, Samuel H. Payne, Kelly V. Ruggles, Karin D. Rodland, Li Ding, Bing Zhang, Tao Liu, David Fenyö, Anupriya Agarwal, Meenakshi Anurag, Dmitry Avtonomov, Chet Birger, Michael J. Birrer, Simina M. Boca, William E. Bocik, Uma Borate, Melissa Borucki, Meghan C. Burke, Shuang Cai, Anna Calinawan, Steven A. Carr, Sonya Carter, Patricia Castro, Sandra Cerda, Michelle Chaikin, Daniel W. Chan, Doug Chan, Alyssa Charamut, Feng Chen, Jin Chen, Lijun Chen, Lin S. Chen, David Chesla, Milan G. Chheda, Arul M. Chinnaiyan, Shrabanti Chowdhury, Marcin P. Cieslik, David J. Clark, Sandra Cottingham, Houston Culpepper, Jacob Day, Stephanie De Young, Emek Demir, Saravana Mohan Dhanasekaran, Rajiv Dhir, Marcin J. Domagalski, Peter Dottino, Brian Druker, Elizabeth Duffy, Maureen Dyer, Nathan J. Edwards, Robert Edwards, Kim Elburn, Jayson B. Field, Alicia Francis, Stacey Gabriel, Yifat Geffen, Daniel Geiszler, Michael A. Gillette, Andrew K. Godwin, Pamela Grady, Linda Hannick, Pushpa Hariharan, Sue Hilsenbeck, Barbara Hindenach, Katherine A. Hoadley, Runyu Hong, Galen Hostetter, James J. Hsieh, Yingwei Hu, Michael M. Ittmann, Eric Jaehnig, Scott D. Jewell, Jiayi Ji, Corbin D. Jones, Renee Karabon, Karen A. Ketchum, Munziba Khan, Beom-Jun Kim, Azra Krek, Tanya Krubit, Chandan Kumar-Sinha, Felipe D. Leprevost, Michael Lewis, Qing Kay Li, Yize Li, Hongwei Liu, Jan Lubinski, Weiping Ma, Rashna Madan, Ewa Malc, Anna Malovannaya, Sailaja Mareedu, Sanford P. Markey, Annette Marrero-Oliveras, John Martignetti, Jason McDermott, Peter B. McGarvey, John McGee, Piotr Mieczkowski, Francesmary Modugno, Rebecca Montgomery, Chelsea J. Newton, Gilbert S. Omenn, Amanda G. Paulovich, Amy M. Perou, Francesca Petralia, Paul Piehowski, Larisa Polonskaya, Liqun Qi, Shannon Richey, Karna Robinson, Nancy Roche, Daniel C. Rohrer, Eric E. Schadt, Michael Schnaubelt, Yan Shi, Tara Skelly, Lori J. Sokoll, Xiaoyu Song, Stephen E. Stein, James Suh, Donghui Tan, Darlene Tansil, Guo Ci Teo, Ratna R. Thangudu, Cristina Tognon, Elie Traer, Jeffrey Tyner, Ki Sung Um, Dana R. Valley, Negin Vatanian, Pankaj Vats, Uma Velvulou, Michael Vernon, Liang-Bo Wang, Ying Wang, Alex Webster, Thomas Westbrook, David Wheeler, Jeffrey R. Whiteaker, George D. Wilson, Yuriy Zakhartsev, Robert Zelt, Hui Zhang, Yuping Zhang, Zhen Zhang & Grace Zhao. (2020) Proteogenomic Characterization of Endometrial Carcinoma. Cell 180:4, pages 729-748.e26.
Crossref
Yuanlong Ge, Shu Wu, Zepeng Zhang, Xiaocui Li, Feng Li, Siyu Yan, Haiying Liu, Junjiu Huang & Yong Zhao. (2019) Inhibition of p53 and/or AKT as a new therapeutic approach specifically targeting ALT cancers. Protein & Cell 10:11, pages 808-824.
Crossref
Min Sung Joo, Sol-Bi Shin, Eun Jung Kim, Hyun Ja Koo, Hyungshin Yim & Sang Geon Kim. (2019) Nrf2‐lncRNA controls cell fate by modulating p53‐dependent Nrf2 activation as an miRNA sponge for Plk2 and p21 cip1 . The FASEB Journal 33:7, pages 7953-7969.
Crossref
Antonina Hafner, Martha L. Bulyk, Ashwini Jambhekar & Galit Lahav. (2019) The multiple mechanisms that regulate p53 activity and cell fate. Nature Reviews Molecular Cell Biology 20:4, pages 199-210.
Crossref
Liren Jiang, Natasha Malik, Pilar Acedo & Joanna Zawacka-Pankau. (2019) Protoporphyrin IX is a dual inhibitor of p53/MDM2 and p53/MDM4 interactions and induces apoptosis in B-cell chronic lymphocytic leukemia cells. Cell Death Discovery 5:1.
Crossref
Sung-Po Hsu, Po-Han Lin, Chih-Ming Chou & Wen-Sen Lee. (2019) Progesterone up-regulates p27 through an increased binding of the progesterone receptor-A-p53 protein complex onto the non-canonical p53 binding motif in HUVEC. The Journal of Steroid Biochemistry and Molecular Biology 185, pages 163-171.
Crossref
Barbara Marengo, Paola Monti, Mariangela Miele, Paola Menichini, Laura Ottaggio, Giorgia Foggetti, Alessandra Pulliero, Alberto Izzotti, Andrea Speciale, Ombretta Garbarino, Nicola Traverso, Gilberto Fronza & Cinzia Domenicotti. (2018) Etoposide-resistance in a neuroblastoma model cell line is associated with 13q14.3 mono-allelic deletion and miRNA-15a/16-1 down-regulation. Scientific Reports 8:1.
Crossref
Jana Čechová, Jan Coufal, Eva B. Jagelská, Miroslav Fojta & Václav Brázda. (2018) p73, like its p53 homolog, shows preference for inverted repeats forming cruciforms. PLOS ONE 13:4, pages e0195835.
Crossref
Melpo Christofidou-Solomidou, Ralph A. Pietrofesa, Evguenia Arguiri, Constantinos Koumenis & Robert Segal. (2017) Radiation Mitigating Properties of Intranasally Administered KL 4 Surfactant in a Murine Model of Radiation-Induced Lung Damage . Radiation Research 188:5, pages 571-584.
Crossref
Václav Brázda & Jan Coufal. (2017) Recognition of Local DNA Structures by p53 Protein. International Journal of Molecular Sciences 18:2, pages 375.
Crossref
Václav Brázda, Jana Čechová, Michele Battistin, Jan Coufal, Eva B. Jagelská, Ivan Raimondi & Alberto Inga. (2017) The structure formed by inverted repeats in p53 response elements determines the transactivation activity of p53 protein. Biochemical and Biophysical Research Communications 483:1, pages 516-521.
Crossref
Andrew T. McKenzie, Igor Katsyv, Won-Min Song, Minghui Wang & Bin Zhang. (2016) DGCA: A comprehensive R package for Differential Gene Correlation Analysis. BMC Systems Biology 10:1.
Crossref
Vasundhara Sharma, Paola Monti, Gilberto Fronza & Alberto Inga. (2016) Human transcription factors in yeast: the fruitful examples of P53 and NF-кB. FEMS Yeast Research 16:7, pages fow083.
Crossref
Annelien Verfaillie, Dmitry Svetlichnyy, Hana Imrichova, Kristofer Davie, Mark Fiers, Zeynep Kalender Atak, Gert Hulselmans, Valerie Christiaens & Stein Aerts. (2016) Multiplex enhancer-reporter assays uncover unsophisticated TP53 enhancer logic. Genome Research 26:7, pages 882-895.
Crossref
Wynand P. Roos, Adam D. Thomas & Bernd Kaina. (2015) DNA damage and the balance between survival and death in cancer biology. Nature Reviews Cancer 16:1, pages 20-33.
Crossref
Toma Tebaldi, Sara Zaccara, Federica Alessandrini, Alessandra Bisio, Yari Ciribilli & Alberto Inga. (2015) Whole-genome cartography of p53 response elements ranked on transactivation potential. BMC Genomics 16:1.
Crossref
Ana Ramos, Pui-Wah Tse, Jessie Wang, Abdul S. Ethayathulla & Hector Viadiu. (2015) Sequence Variation in the Response Element Determines Binding by the Transcription Factor p73. Biochemistry 54:47, pages 6961-6972.
Crossref
Vasundhara Sharma, Jennifer J. Jordan, Yari Ciribilli, Michael A. Resnick, Alessandra Bisio & Alberto Inga. (2015) Quantitative Analysis of NF-κB Transactivation Specificity Using a Yeast-Based Functional Assay. PLOS ONE 10:7, pages e0130170.
Crossref
Nicolas Jullien, Catherine Roche, Thierry Brue, Dominique Figarella-Branger, Thomas Graillon, Anne Barlier & Jean-Paul Herman. (2015) Dose-Dependent Dual Role of PIT-1 (POU1F1) in Somatolactotroph Cell Proliferation and Apoptosis. PLOS ONE 10:3, pages e0120010.
Crossref
Mattia Lion, Ivan Raimondi, Stefano Donati, Olivier Jousson, Yari Ciribilli & Alberto Inga. (2015) Evolution of p53 Transactivation Specificity through the Lens of a Yeast-Based Functional Assay. PLOS ONE 10:2, pages e0116177.
Crossref
Qian Hao & William Cho. (2014) Battle Against Cancer: An Everlasting Saga of p53. International Journal of Molecular Sciences 15:12, pages 22109-22127.
Crossref
C Saiz-Ladera, M F Lara, M Garín, S Ruiz, M Santos, C Lorz, R García-Escudero, M Martínez-Fernández, A Bravo, O Fernández-Capetillo, C Segrelles & J M Paramio. (2013) p21 suppresses inflammation and tumorigenesis on pRB-deficient stratified epithelia. Oncogene 33:37, pages 4599-4612.
Crossref
Paola MontiYari CiribilliAlessandra BisioGiorgia FoggettiIvan RaimondiPaola Campomenosi, Paola MenichiniGilberto FronzaAlberto Inga. (2014) ΔN-P63α and TA-P63α exhibit intrinsic differences in transactivation specificities that depend on distinct features of DNA target sites. Oncotarget 5:8, pages 2116-2130.
Crossref
Diana Marouco, Alexander V. Garabadgiu, Gerry Melino & Nikolai A. Barlev. (2013) Lysine-specific modifications of p53: a matter of life and death?. Oncotarget 4:10, pages 1556-1571.
Crossref
Y. Ciribilli, P. Monti, A. Bisio, H. T. Nguyen, A. S. Ethayathulla, A. Ramos, G. Foggetti, P. Menichini, D. Menendez, M. A. Resnick, H. Viadiu, G. Fronza & A. Inga. (2013) Transactivation specificity is conserved among p53 family proteins and depends on a response element sequence code. Nucleic Acids Research 41:18, pages 8637-8653.
Crossref
Ivan Raimondi, Yari Ciribilli, Paola Monti, Alessandra Bisio, Loredano Pollegioni, Gilberto Fronza, Alberto Inga & Paola Campomenosi. (2013) P53 Family Members Modulate the Expression of PRODH, but Not PRODH2, via Intronic p53 Response Elements. PLoS ONE 8:7, pages e69152.
Crossref
Zixiang Zhu, Jianchao Wei, Zixue Shi, Yifan Yang, Donghua Shao, Beibei Li, Xiaodu Wang & Zhiyong Ma. (2013) Identification of human guanylate-binding protein 1 gene (hGBP1) as a direct transcriptional target gene of p53. Biochemical and Biophysical Research Communications 436:2, pages 204-211.
Crossref
Paola Monti, Debora Russo, Renata Bocciardi, Giorgia Foggetti, Paola Menichini, Maria T. Divizia, Margherita Lerone, Claudio Graziano, Anita Wischmeijer, Hector Viadiu, Roberto Ravazzolo, Alberto Inga & Gilberto Fronza. (2013) EEC- and ADULT-Associated TP63 Mutations Exhibit Functional Heterogeneity Toward P63 Responsive Sequences . Human Mutation 34:6, pages 894-904.
Crossref
Luis A Carvajal & James J Manfredi. (2013) Another fork in the road—life or death decisions by the tumour suppressor p53. EMBO reports 14:5, pages 414-421.
Crossref
Mariana Leão, Clara Pereira, Alessandra Bisio, Yari Ciribilli, Ana M. Paiva, Neuza Machado, Andreia Palmeira, Miguel X. Fernandes, Emília Sousa, Madalena Pinto, Alberto Inga & Lucília Saraiva. (2013) Discovery of a new small-molecule inhibitor of p53–MDM2 interaction using a yeast-based approach. Biochemical Pharmacology 85:9, pages 1234-1245.
Crossref
Mariana Leão, Sara Gomes, José Pedraza-Chaverri, Neuza Machado, Emília Sousa, Madalena Pinto, Alberto Inga, Clara Pereira & Lucília Saraiva. (2013) α-Mangostin and Gambogic Acid as Potential Inhibitors of the p53–MDM2 Interaction Revealed by a Yeast Approach. Journal of Natural Products 76:4, pages 774-778.
Crossref
W Wang, B Cheng, L Miao, Y Mei & M Wu. (2013) Mutant p53-R273H gains new function in sustained activation of EGFR signaling via suppressing miR-27a expression. Cell Death & Disease 4:4, pages e574-e574.
Crossref
Myriam Loyo, Ryan J. Li, Chetan Bettegowda, Curtis R. Pickering, Mitchell J. Frederick, Jeffrey N. Myers & Nishant Agrawal. (2013) Lessons learned from next-generation sequencing in head and neck cancer. Head & Neck 35:3, pages 454-463.
Crossref
Magali Olivier. 2013. p53 in the Clinics. p53 in the Clinics 127 146 .
Jennifer J. Jordan, Daniel Menendez, Jenia Sharav, Itai Beno, Karin Rosenthal, Michael A. Resnick & Tali E. Haran. (2012) Low-level p53 expression changes transactivation rules and reveals superactivating sequences. Proceedings of the National Academy of Sciences 109:36, pages 14387-14392.
Crossref
Limor Leibovich & Zohar Yakhini. (2012) Efficient motif search in ranked lists and applications to variable gap motifs. Nucleic Acids Research 40:13, pages 5832-5847.
Crossref
Keng Boon Wee, Wee Kheng Yio, Uttam Surana & Keng Hwee Chiam. (2012) Transcription Factor Oscillations Induce Differential Gene Expressions. Biophysical Journal 102:11, pages 2413-2423.
Crossref
Monika Aggarwal & Robert M. BroshJr.Jr.. (2012) Functional analyses of human DNA repair proteins important for aging and genomic stability using yeast genetics. DNA Repair 11:4, pages 335-348.
Crossref
Jing Zhao, Yixin Lu & Han-Ming Shen. (2012) Targeting p53 as a therapeutic strategy in sensitizing TRAIL-induced apoptosis in cancer cells. Cancer Letters 314:1, pages 8-23.
Crossref
Dongjin Sung, Sara A Kaltreider & Federico Gonzalez-Fernandez. (2011) Early onset sebaceous carcinoma. Diagnostic Pathology 6:1.
Crossref
Yunyuan V. Wang, Mathias Leblanc, Norma Fox, Jian-Hua Mao, Kelsey L. Tinkum, Kurt Krummel, Dannielle Engle, David Piwnica-Worms, Helen Piwnica-Worms, Allan Balmain, Kenneth Kaushansky & Geoffrey M. Wahl. (2011) Fine-tuning p53 activity through C-terminal modification significantly contributes to HSC homeostasis and mouse radiosensitivity. Genes & Development 25:13, pages 1426-1438.
Crossref
Virginia Andreotti, Yari Ciribilli, Paola Monti, Alessandra Bisio, Mattia Lion, Jennifer Jordan, Gilberto Fronza, Paola Menichini, Michael A. Resnick & Alberto Inga. (2011) p53 Transactivation and the Impact of Mutations, Cofactors and Small Molecules Using a Simplified Yeast-Based Screening System. PLoS ONE 6:6, pages e20643.
Crossref
John L. Rinn & Maite Huarte. (2011) To repress or not to repress: This is the guardian's question. Trends in Cell Biology 21:6, pages 344-353.
Crossref
Jean-François Millau, Omari J. Bandele, Josiann Perron, Nathalie Bastien, Éric F. Bouchard, Luc Gaudreau, Douglas A. Bell & Régen Drouin. (2011) Formation of stress-specific p53 binding patterns is influenced by chromatin but not by modulation of p53 binding affinity to response elements †. Nucleic Acids Research 39:8, pages 3053-3063.
Crossref
Itai Beno, Karin Rosenthal, Michael Levitine, Lihi Shaulov & Tali E. Haran. (2011) Sequence-dependent cooperative binding of p53 to DNA targets and its relationship to the structural properties of the DNA targets. Nucleic Acids Research 39:5, pages 1919-1932.
Crossref
Wen-Yu Huang, Pei-Ming Yang, Yu-Fan Chang, Victor E. Marquez & Ching-Chow Chen. (2011) Methotrexate induces apoptosis through p53/p21-dependent pathway and increases E-cadherin expression through downregulation of HDAC/EZH2. Biochemical Pharmacology 81:4, pages 510-517.
Crossref
Omari J. Bandele, Xuting Wang, Michelle R. Campbell, Gary S. Pittman & Douglas A. Bell. (2011) Human single-nucleotide polymorphisms alter p53 sequence-specific binding at gene regulatory elements. Nucleic Acids Research 39:1, pages 178-189.
Crossref
Suresh Anaganti, Lynnette Fernández-Cuesta, Anita Langerød, Pierre Hainaut & Magali Olivier. (2011) p53-Dependent repression of focal adhesion kinase in response to estradiol in breast cancer cell-lines. Cancer Letters 300:2, pages 215-224.
Crossref
Alexander Hunziker, Mogens H Jensen & Sandeep Krishna. (2010) Stress-specific response of the p53-Mdm2 feedback loop. BMC Systems Biology 4:1.
Crossref
Anna Phillips, Amina Teunisse, Suzanne Lam, Kirsten Lodder, Matthew Darley, Muhammad Emaduddin, Anja Wolf, Julia Richter, Job de Lange, Matty Verlaan-de Vries, Kristiaan Lenos, Anja Böhnke, Frank Bartel, Jeremy P. Blaydes & Aart G. Jochemsen. (2010) HDMX-L Is Expressed from a Functional p53-responsive Promoter in the First Intron of the HDMX Gene and Participates in an Autoregulatory Feedback Loop to Control p53 Activity. Journal of Biological Chemistry 285:38, pages 29111-29127.
Crossref
Jennifer J. Jordan, Alberto Inga, Kathleen Conway, Sharon Edmiston, Lisa A. Carey, Lin Wu & Michael A. Resnick. (2010) Altered-Function p53 Missense Mutations Identified in Breast Cancers Can Have Subtle Effects on Transactivation. Molecular Cancer Research 8:5, pages 701-716.
Crossref
Michael L. Davies, Shushen Xu, James Lyons-Weiler, Adam Rosendorff, Steven A. Webber, Laura R. Wasil, Diana Metes & David T. Rowe. (2010) Cellular factors associated with latency and spontaneous Epstein–Barr virus reactivation in B-lymphoblastoid cell lines. Virology 400:1, pages 53-67.
Crossref
Daniel Menendez, Alberto Inga & Michael A. Resnick. (2010) Estrogen receptor acting in cis enhances WT and mutant p53 transactivation at canonical and noncanonical p53 target sequences . Proceedings of the National Academy of Sciences 107:4, pages 1500-1505.
Crossref
Alberto Inga, Jennifer J. Jordan, Daniel Menendez, Veronica De Sanctis & Michael A. Resnick. 2010. Handbook of Cell Signaling. Handbook of Cell Signaling 2205 2216 .
Sivakumar Gowrisankar & Anil G Jegga. (2009) Regression based predictor for p53 transactivation. BMC Bioinformatics 10:1.
Crossref
E Drakos, V Atsaves, E Schlette, J Li, I Papanastasi, G Z Rassidakis & L J Medeiros. (2009) The therapeutic potential of p53 reactivation by nutlin-3a in ALK+ anaplastic large cell lymphoma with wild-type or mutated p53. Leukemia 23:12, pages 2290-2299.
Crossref
Daniel Menendez, Alberto Inga & Michael A. Resnick. (2009) The expanding universe of p53 targets. Nature Reviews Cancer 9:10, pages 724-737.
Crossref
Józefa Węsierska-Gądek, Eva Walzi, Iva Dolečkova & Gerald Schmid. (2009) Oncogenes do not Fully Override Cell-intrinsic Traits: Pronounced Impact of the Cellular Programme. Cancer Microenvironment 2:S1, pages 215-225.
Crossref
Bei Wang, Ziwei Xiao & Ee Chee Ren. (2009) Redefining the p53 response element. Proceedings of the National Academy of Sciences 106:34, pages 14373-14378.
Crossref
Raymond L. Warters, Ann T. Packard, Gwen F. Kramer, David K. Gaffney & Philip J. Moos. (2009) Differential Gene Expression in Primary Human Skin Keratinocytes and Fibroblasts in Response to Ionizing Radiation. Radiation Research 172:1, pages 82.
Crossref
Jun Yan, Daniel Menendez, Xiao-Ping Yang, Michael A. Resnick & Anton M. Jetten. (2009) A Regulatory Loop Composed of RAP80-HDM2-p53 Provides RAP80-enhanced p53 Degradation by HDM2 in Response to DNA Damage. Journal of Biological Chemistry 284:29, pages 19280-19289.
Crossref
Maher A. Noureddine, Daniel Menendez, Michelle R. Campbell, Omari J. Bandele, Monica M. Horvath, Xuting Wang, Gary S. Pittman, Brian N. Chorley, Michael A. Resnick & Douglas A. Bell. (2009) Probing the Functional Impact of Sequence Variation on p53-DNA Interactions Using a Novel Microsphere Assay for Protein-DNA Binding with Human Cell Extracts. PLoS Genetics 5:5, pages e1000462.
Crossref
Gerald Schmid, Matthias P. Kramer & Józefa Węsierska-Gądek. (2009) p53-mediated regulation of cell cycle progression: Pronounced impact of cellular microenvironment. Journal of Cellular Physiology 219:2, pages 459-469.
Crossref
Kerry J. Kim & Vilaiwan M. Fernandes. (2009) Effects of Ploidy and Recombination on Evolution of Robustness in a Model of the Segment Polarity Network. PLoS Computational Biology 5:2, pages e1000296.
Crossref
Jun Chen, Sok Meng Ng, Changqing Chang, Zhenhai Zhang, Jean-Christophe Bourdon, David P. Lane & Jinrong Peng. (2009) p53 isoform Δ113p53 is a p53 target gene that antagonizes p53 apoptotic activity via BclxL activation in zebrafish. Genes & Development 23:3, pages 278-290.
Crossref
Tomasz Zemojtel, Szymon M. Kielbasa, Peter F. Arndt, Ho-Ryun Chung & Martin Vingron. (2009) Methylation and deamination of CpGs generate p53-binding sites on a genomic scale. Trends in Genetics 25:2, pages 63-66.
Crossref
Miriana Petrovich & Dmitry B. Veprintsev. (2009) Effects of CpG Methylation on Recognition of DNA by the Tumour Suppressor p53. Journal of Molecular Biology 386:1, pages 72-80.
Crossref
John C. Scatizzi & Harris Perlman. 2009. Kelley's Textbook of Rheumatology. Kelley's Textbook of Rheumatology 337 342 .
Jennifer J. Jordan, Daniel Menendez, Alberto Inga, Maher Nourredine, Douglas Bell & Michael A. Resnick. (2008) Noncanonical DNA Motifs as Transactivation Targets by Wild Type and Mutant p53. PLoS Genetics 4:6, pages e1000104.
Crossref
Leonie Smeenk, Simon J. van Heeringen, Max Koeppel, Marc A. van Driel, Stefanie J. J. Bartels, Robert C. Akkers, Sergei Denissov, Hendrik G. Stunnenberg & Marion Lohrum. (2008) Characterization of genome-wide p53-binding sites upon stress response. Nucleic Acids Research 36:11, pages 3639-3654.
Crossref
Yongping Pan & Ruth Nussinov. (2008) p53-Induced DNA Bending: The Interplay between p53−DNA and p53−p53 Interactions. The Journal of Physical Chemistry B 112:21, pages 6716-6724.
Crossref
Todd Riley, Eduardo Sontag, Patricia Chen & Arnold Levine. (2008) Transcriptional control of human p53-regulated genes. Nature Reviews Molecular Cell Biology 9:5, pages 402-412.
Crossref
Dae-Hee Lee, Clifford Kim, Lin Zhang & Yong J. Lee. (2008) Role of p53, PUMA, and Bax in wogonin-induced apoptosis in human cancer cells. Biochemical Pharmacology 75:10, pages 2020-2033.
Crossref
D Grochova, J Vankova, J Damborsky, B Ravcukova, J Smarda, B Vojtesek & J Smardova. (2007) Analysis of transactivation capability and conformation of p53 temperature-dependent mutants and their reactivation by amifostine in yeast. Oncogene 27:9, pages 1243-1252.
Crossref
Elena J Edelman, Justin Guinney, Jen-Tsan Chi, Phillip G Febbo & Sayan Mukherjee. (2008) Modeling Cancer Progression via Pathway Dependencies. PLoS Computational Biology 4:2, pages e28.
Crossref
Anil G. JeggaAlberto Inga, Daniel Menendez, Bruce J. AronowMichael A. Resnick. (2008) Functional evolution of the p53 regulatory network through its target response elements. Proceedings of the National Academy of Sciences 105:3, pages 944-949.
Crossref
P. M. Chumakov. (2007) Versatile functions of p53 protein in multicellular organisms. Biochemistry (Moscow) 72:13, pages 1399-1421.
Crossref
C A Perez, J Ott, D J Mays & J A Pietenpol. (2007) p63 consensus DNA-binding site: identification, analysis and application into a p63MH algorithm. Oncogene 26:52, pages 7363-7370.
Crossref
C R Landry, D L Hartl & J M Ranz. (2007) Genome clashes in hybrids: insights from gene expression. Heredity 99:5, pages 483-493.
Crossref
Thierry Soussi & Klas G. Wiman. (2007) Shaping Genetic Alterations in Human Cancer: The p53 Mutation Paradigm. Cancer Cell 12:4, pages 303-312.
Crossref
Jarmila Navrátilová, Viktor Horváth, Alois Kozubík, Antonín Lojek, Joseph Lipsick & Jan Šmarda. (2007) p53 arrests growth and induces differentiation of v-Myb-transformed monoblasts. Differentiation 75:7, pages 592-604.
Crossref
Veenu Tripathi, Amjad Ali, Rajiv Bhat & Uttam Pati. (2007) CHIP Chaperones Wild Type p53 Tumor Suppressor Protein. Journal of Biological Chemistry 282:39, pages 28441-28454.
Crossref
Joshua Merritt, Kim G. Roberts, James A. Butz & Jeremy S. Edwards. (2007) Parallel analysis of tetramerization domain mutants of the human p53 protein using PCR colonies. Genomic Medicine 1:3-4, pages 113-124.
Crossref
Yael Aylon & Moshe Oren. (2007) Living with p53, Dying of p53. Cell 130:4, pages 597-600.
Crossref
Paola Monti, Yari Ciribilli, Jennifer Jordan, Paola Menichini, David M. Umbach, Michael A. Resnick, Lucio Luzzatto, Alberto Inga & Gilberto Fronza. (2007) Transcriptional Functionality of Germ Line p53 Mutants Influences Cancer Phenotype. Clinical Cancer Research 13:13, pages 3789-3795.
Crossref
Buyong Ma, Yongping Pan, Jie Zheng, Arnold J. Levine & Ruth Nussinov. (2007) Sequence analysis of p53 response-elements suggests multiple binding modes of the p53 tetramer to DNA targets. Nucleic Acids Research 35:9, pages 2986-3001.
Crossref
L Weisz, M Oren & V Rotter. (2007) Transcription regulation by mutant p53. Oncogene 26:15, pages 2202-2211.
Crossref
D Menendez, A Inga, J J Jordan & M A Resnick. (2007) Changing the p53 master regulatory network: ELEMENTary, my dear Mr Watson. Oncogene 26:15, pages 2191-2201.
Crossref
Motonobu Osada, Hannah Lui Park, Min Joo Park, Jun-Wei Liu, Guojun Wu, Barry Trink & David Sidransky. (2007) A p53-type response element in the GDF15 promoter confers high specificity for p53 activation. Biochemical and Biophysical Research Communications 354:4, pages 913-918.
Crossref
Maria Lokshin, Yingchun Li, Christian Gaiddon & Carol Prives. (2007) p53 and p73 display common and distinct requirements for sequence specific binding to DNA. Nucleic Acids Research 35:1, pages 340-352.
Crossref
Geoffrey M. Wahl, Jayne M. Stommel, Kurt Krummel & Mark Wade. 2007. 25 Years of p53 Research. 25 Years of p53 Research 73 113 .
Luciana E. Giono & James J. Manfredi. (2006) The p53 tumor suppressor participates in multiple cell cycle checkpoints. Journal of Cellular Physiology 209:1, pages 13-20.
Crossref
Eveline Barbieri, Parth Mehta, Zaowen Chen, Linna Zhang, Andrew Slack, Stacey Berg & Jason M. Shohet. (2006) MDM2 inhibition sensitizes neuroblastoma to chemotherapy-induced apoptotic cell death. Molecular Cancer Therapeutics 5:9, pages 2358-2365.
Crossref
Daniel A. Hamstra, Mahaveer S. Bhojani, Laura B. Griffin, Bharathi Laxman, Brian D. Ross & Alnawaz Rehemtulla. (2006) Real-time Evaluation of p53 Oscillatory Behavior In vivo Using Bioluminescent Imaging . Cancer Research 66:15, pages 7482-7489.
Crossref
O Laptenko & C Prives. (2006) Transcriptional regulation by p53: one protein, many possibilities. Cell Death & Differentiation 13:6, pages 951-961.
Crossref
Malka Kitayner, Haim Rozenberg, Naama Kessler, Dov Rabinovich, Lihi Shaulov, Tali E. Haran & Zippora Shakked. (2006) Structural Basis of DNA Recognition by p53 Tetramers. Molecular Cell 22:6, pages 741-753.
Crossref
Paola Di Lello, Lisa M. Miller Jenkins, Tamara N. Jones, Bao D. Nguyen, Toshiaki Hara, Hiroshi Yamaguchi, Jimmy D. Dikeakos, Ettore Appella, Pascale Legault & James G. Omichinski. (2006) Structure of the Tfb1/p53 Complex: Insights into the Interaction between the p62/Tfb1 Subunit of TFIIH and the Activation Domain of p53. Molecular Cell 22:6, pages 731-740.
Crossref
Sündüz KeleşMark J. Van Der LaanSandrine DudoitSimon E. Cawley. (2006) Multiple Testing Methods For ChIP–Chip High Density Oligonucleotide Array Data. Journal of Computational Biology 13:3, pages 579-613.
Crossref
Václav Brázda, Eva Brázdová Jagelská, Miroslav Fojta & Emil Paleček. (2006) Searching for target sequences by p53 protein is influenced by DNA length. Biochemical and Biophysical Research Communications 341:2, pages 470-477.
Crossref
D Speidel, H Helmbold & W Deppert. (2005) Dissection of transcriptional and non-transcriptional p53 activities in the response to genotoxic stress. Oncogene 25:6, pages 940-953.
Crossref
Motonobu Osada, Hannah Lui Park, Yuichi Nagakawa, Shahnaz Begum, Keishi Yamashita, Guojun Wu, Myoung Sook Kim, Barry Trink & David Sidransky. (2006) A novel response element confers p63- and p73-specific activation of the WNT4 promoter. Biochemical and Biophysical Research Communications 339:4, pages 1120-1128.
Crossref
Christian R Landry, Patricia J Wittkopp, Clifford H Taubes, Jose M Ranz, Andrew G Clark & Daniel L Hartl. (2005) Compensatory cis-trans Evolution and the Dysregulation of Gene Expression in Interspecific Hybrids of Drosophila . Genetics 171:4, pages 1813-1822.
Crossref
L. Kevin Lewis, Kirill Lobachev, James W. Westmoreland, G. Karthikeyan, Kelly M. Williamson, Jennifer J. Jordan & Michael A. Resnick. (2005) Use of a restriction endonuclease cytotoxicity assay to identify inducible GAL1 promoter variants with reduced basal activity. Gene 363, pages 183-192.
Crossref
Lea Spyres, Sally Gaddis, Ella Bedford, Stacey Arantes, Nikki Liburd, K. Leslie Powell, Howard Thames, David Mitchell, Earl Walborg, Mahmoud Rouabhia, C. Marcelo Aldaz & Michael C. MacLeod. (2005) Quantitative high-throughput measurement of gene expression with sub-zeptomole sensitivity by capillary electrophoresis. Analytical Biochemistry 345:2, pages 284-295.
Crossref
Alberto Inga, Stella Marie Reamon-Buettner, Juergen Borlak & Michael A. Resnick. (2005) Functional dissection of sequence-specific NKX2-5 DNA binding domain mutations associated with human heart septation defects using a yeast-based system. Human Molecular Genetics 14:14, pages 1965-1975.
Crossref
Jana Šmardová, Jan Šmarda & Jana Koptíková. (2005) Functional analysis of p53 tumor suppressor in yeast. Differentiation 73:6, pages 261-277.
Crossref
Motonobu Osada, Yuichi Nagakawa, Hannah Lui Park, Keishi Yamashita, Guojun Wu, Myoung Sook Kim, Alexey Fomenkov, Barry Trink & David Sidransky. (2005) p63-Specific Activation of the BPAG-1e Promoter. Journal of Investigative Dermatology 125:1, pages 52-60.
Crossref
Daniel J. Tomso, Alberto Inga, Daniel Menendez, Gary S. Pittman, Michelle R. Campbell, Francesca Storici, Douglas A. Bell & Michael A. Resnick. (2005) Functionally distinct polymorphic sequences in the human genome that are targets for p53 transactivation. Proceedings of the National Academy of Sciences 102:18, pages 6431-6436.
Crossref
Mary C. Thomas & Cheng-Ming Chiang. (2005) E6 Oncoprotein Represses p53-Dependent Gene Activation via Inhibition of Protein Acetylation Independently of Inducing p53 Degradation. Molecular Cell 17:2, pages 251-264.
Crossref
D. Falke, M.H. Fisher & R.L. Juliano. (2004) Selective transcription of p53 target genes by zinc finger–p53 DNA binding domain chimeras. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression 1681:1, pages 15-27.
Crossref
Osnat Ashur-Fabian, Aaron Avivi, Luba Trakhtenbrot, Konstantin Adamsky, Meytal Cohen, Gadi Kajakaro, Alma Joel, Ninette Amariglio, Eviatar Nevo & Gideon Rechavi. (2004) Evolution of p53 in hypoxia-stressed Spalax mimics human tumor mutation . Proceedings of the National Academy of Sciences 101:33, pages 12236-12241.
Crossref
Emmanuel Maillart, Karen Brengel-Pesce, Delphine Capela, André Roget, Thierry Livache, Michael Canva, Yves Levy & Thierry Soussi. (2004) Versatile analysis of multiple macromolecular interactions by SPR imaging: application to p53 and DNA interaction. Oncogene 23:32, pages 5543-5550.
Crossref
Zoya N. Demidenko & Mikhail V. Blagosklonny. (2004) Flavopiridol Induces p53 via Initial Inhibition of Mdm2 and p21 and, Independently of p53, Sensitizes Apoptosis-Reluctant Cells to Tumor Necrosis Factor. Cancer Research 64:10, pages 3653-3660.
Crossref
Giusy FiucciSéverine BeaucourtDominique DuflautAlexandra LespagnolPamela Stumptner-CuveletteAnne GéantGilles BuchwalterMarcel TuynderLaurent SusiniJean-Michel LassalleChristine WasylykBohdan WasylykMoshe OrenRobert AmsonAdam Telerman. (2004) Siah-1b is a direct transcriptional target of p53: Identification of the functional p53 responsive element in the siah-1b promoter. Proceedings of the National Academy of Sciences 101:10, pages 3510-3515.
Crossref
Petra de Graaf, Natalie A. Little, Yolande F.M. Ramos, Erik Meulmeester, Stef J.F. Letteboer & Aart G. Jochemsen. (2003) Hdmx Protein Stability Is Regulated by the Ubiquitin Ligase Activity of Mdm2. Journal of Biological Chemistry 278:40, pages 38315-38324.
Crossref
Peter Hohenstein & Rachel H. Giles. (2003) BRCA1: a scaffold for p53 response?. Trends in Genetics 19:9, pages 489-494.
Crossref
Michael A. Resnick & Alberto Inga. (2003) Functional mutants of the sequence-specific transcription factor p53 and implications for master genes of diversity. Proceedings of the National Academy of Sciences 100:17, pages 9934-9939.
Crossref
Ella Kim & Wolfgang Deppert. (2003) The complex interactions of p53 with target DNA: we learn as we go. Biochemistry and Cell Biology 81:3, pages 141-150.
Crossref
Milena Gasco & Tim Crook. (2003) The p53 network in head and neck cancer. Oral Oncology 39:3, pages 222-231.
Crossref
Sandra J. Jacobson, Patricia M. Laurenson & Lorraine Pillus. 2003. Chromatin and Chromatin Remodeling Enzymes, Part C. Chromatin and Chromatin Remodeling Enzymes, Part C 3 55 .
Francesca Storici & Michael A. Resnick. 2003. Genetic Engineering. Genetic Engineering 189 207 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.